A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
NCT06006598 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-05-14
Summary
The main objectives of this trial are to investigate safety, tolerability, and pharmacokinetics of BI 1584862 in healthy male subjects following administration of multiple rising doses.
Conditions
- Healthy
Interventions
- DRUG
-
BI 1584862
BI 1584862
- DRUG
-
Placebo matching BI 1584862
Placebo matching BI 1584862
- DRUG
-
midazolam
midazolam
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-28
- Primary Completion
- 2024-05-05
- Completion
- 2024-05-05
Countries
- Germany
Study Locations
More Related Trials
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
NCT04958252 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT04866160 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
NCT06081530 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses
NCT01505894 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
NCT03175211 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers
NCT01958060 ·Status: TERMINATED ·Phase: PHASE1
-
A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men
NCT03875001 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Men Tolerate Different Doses of BI 3006337
NCT05076422 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated
NCT06310005 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT03868540 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated
NCT06139341 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated
NCT03608072 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated
NCT03259464 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
NCT01638598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
NCT06494774 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306
NCT01611311 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
NCT04666922 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated
NCT05183347 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated
NCT05469646 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT05183360 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated
NCT04439838 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects
NCT03195088 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers
NCT02244203 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
NCT01650155 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1